Carbenicillin Disodium

็พง่‹„่ฅฟๆž—้’ 

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameCarbenicillin Disodium
Drug Alias Namecarbenicillinum็พง่‹„้’้œ‰็ด ไบŒ้’ ็พŸ่‹„้’้œ‰็ด ้’ carbenicilina็พง่‹„้’้œ‰็ด ้’  +[6]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsPseudomonas Infections
Global Approved IndicationsPseudomonas Infections
Approved Indications in ChinaPseudomonas Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1966/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesGlaxosmithkline Plc
Active IndicationsPseudomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CA03